Supriya peshin (@supriyadocc) 's Twitter Profile
Supriya peshin

@supriyadocc

Resident Physician @balladhealth | Research fellow @pennmedicine @keckmedicineUSC l @ASCO Featured voice I SOHO young scholar recipient I HemeOnc Aspirant

ID: 1731357092601110528

linkhttps://pubmed.ncbi.nlm.nih.gov/?term=Supriya+peshin&size=20 calendar_today03-12-2023 16:58:18

989 Tweet

427 Followers

369 Following

Together4Cancer (@t4cancer) 's Twitter Profile Photo

Early onset cancers, healthcare disparities, clinical trials - you know you have a fantastic GI oncologist in making when the heart is set on these things at the beginning of the journey itself. More power to you, Supriya peshin! Maybe another Mark Lewis, MD, FASCO in making. With 5

Stephanie A. Haddad, DO (@drsahaddad) 's Twitter Profile Photo

Check out this incredible #hemoncapplicant we’ve had the opportunity to connect and work together! I can’t wait to see all the great things you do, I’m beyond honored to be one of your mentors Hem-Onc Fellows Network H.O.M.E OncoDaily

Claudia Villa Celi (@claudsvillaceli) 's Twitter Profile Photo

My dear friend Supriya peshin has applied for the HemeOnc fellowship, and she is truly a force to be reckoned with. She inspires me and has supported me through thick and thin. I couldn’t be prouder of her, and any program would be lucky to have her! ♥️🤩

Mamtha Balla, MD, MPH, FACP (@mamthab) 's Twitter Profile Photo

Meet Supriya peshin a passionate and driven Hematology-Oncology with a keen interest in Gastrointestinal Oncology! 🌟💊 Good luck to you gal.. I know you will do it 👍🏻👍🏻

Sakditad “Tew” Saowapa, MD (@sakditadmd) 's Twitter Profile Photo

Wishing Supriya all the best as she enters this Hematology-Oncology fellowship application cycle! Her strong passion for GI Oncology, dedication to clinical trials, and focus on healthcare disparities make her an outstanding candidate. Any program would be lucky to have her on

Supriya peshin (@supriyadocc) 's Twitter Profile Photo

Publication Alert🔔 Pancreatic cancer remains one of the toughest cancers. But progress is being made from better surgery and neoadjuvant strategies to targeted therapies. mdpi.com/3414734 #mdpiijms via IJMS MDPI OncoDaily Ehab Takrori @sakshisingal2 Faizan B

OncLive.com (@onclive) 's Twitter Profile Photo

Shubham Pant, MD, MBBS and Rachna Shroff, MD, MS, FASCO highlight how recent breakthroughs in KRAS-specific inhibitors—such as those targeting G12C, G12D, and G12V mutations—are transforming the management of pancreatic cancer. Watch more here: hubs.li/Q03ybLky0

OncoDaily (@oncodaily) 's Twitter Profile Photo

Pancreatic Cancer Remains One of the Toughest Cancers - Supriya peshin oncodaily.com/insight/supriy… #PancreaticCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews CancerWorld

Pancreatic Cancer Remains One of the Toughest Cancers - <a href="/supriyadocc/">Supriya peshin</a> 

oncodaily.com/insight/supriy…

#PancreaticCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
<a href="/CancerWorldmag/">CancerWorld</a>